Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
AI Roadmap for Enterprises: Why Sequencing Beats Speed
Most enterprises have launched AI pilots. Fewer have scaled them. That gap between a demo that impressed the board and a system running in production is where most AI roadmap for enterprises…
|
AI Roadmap 2026
The Fundamentals of AI RoadmapsLeading analysts define an AI Roadmap as a sequenced plan across strategy, data, governance, talent, and engineering. It aligns initiatives with business goals. It…
|
AI Strategy: 2026 Enterprise Playbook
AI Strategy starts with business outcomes first. Leaders map high-impact use cases that directly affect revenue, cost, or customer experience. They run readiness assessments across data quality,…
|
AI Consultancy: 2026 Enterprise Buyer’s Guide
Your team evaluated AI tools. Reports listed top firms. Yet many projects deliver short-term wins followed by stalled progress. You need more than a vendor list.AI Consultancy has matured into a…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
